Gao, Yongqian <br/><br/>
Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway.  [electronic resource] 

 -  Oncotarget  09 2016 
 - 63374-63387 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.11463  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenomedullin--antagonists & inhibitors<br/>Animals<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Humans<br/>Indoles--pharmacology<br/>Kidney Neoplasms--drug therapy<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Prognosis<br/>Pyrroles--pharmacology<br/>Sunitinib<br/>Survival Rate<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays